Bristol Myers Squibb Co (BMY) Income towards Parent Company (2009 - 2026)

Bristol Myers Squibb (BMY) has reported Income towards Parent Company for 18 consecutive years, with $3.3 billion the latest figure, recorded in Q2 2026.

• In Q2 2026, Income towards Parent Company rose 152.55% year-over-year to $3.3 billion; the TTM figure through Jun 2026 stood at $9.3 billion (up 83.1% YoY), while the FY2025 annual figure was $7.1 billion, up 178.99% from the prior year.
• Income towards Parent Company grew to $3.3 billion in Q2 2026 per BMY's latest filing, from $2.7 billion in the prior quarter.
• Across five years, Income towards Parent Company topped out at $3.3 billion in Q2 2026 and bottomed at -$11.9 billion in Q1 2024.
• Historically, Income towards Parent Company has averaged $1.0 billion across 5 years, with a median of $1.7 billion in 2023.
• Annual changes were most pronounced in 2024 — Income towards Parent Company sank 625.28% — and 2025, when it soared 1328.95%.
• Bristol Myers Squibb's Income towards Parent Company stood at $2.0 billion in 2022, then declined by 12.99% to $1.8 billion in 2023, then slumped by 95.69% to $76.0 million in 2024, then jumped by 1328.95% to $1.1 billion in 2025, then surged by 205.34% to $3.3 billion in 2026.
• Business Quant data shows BMY's Income towards Parent Company at $3.3 billion in Q2 2026, $2.7 billion in Q1 2026, and $1.1 billion in Q4 2025.